Adelaide, October 2024 – Altera Digital Health is pleased to announce the successful go-live of its advanced electronic chemotherapy prescribing solution, iQemo, at the Royal Adelaide Hospital (RAH), Central Adelaide Local Health Network. This milestone marks a significant expansion of the state-wide rollout of SA Health’s Enterprise Chemotherapy Prescribing System (ECPS), designed to enhance cancer treatment for both adults and children across South Australia.

The RAH is South Australia’s flagship hospital, providing a comprehensive range of the most complex clinical care to an estimated 85,000 inpatients and 400,000 outpatients each year. The RAH is one of Australia’s most technologically advanced healthcare facilities, integrating the latest innovations across health, education and research to deliver high-quality care. The implementation of iQemo is an example of technological advancement and lastest innovation in cancer care delivery.

The ECPS project supports the implementation of consistent and standardised systemic cancer therapy processes, improving cancer patient safety and outcomes. ECPS has been initiated to achieve the vision of safe and timely provision of high-quality, evidence-based cancer care to the South Australian population. Following the go-live at the Royal Adelaide Hospital, there are more than 450 clinicians and healthcare administrators manage over 1,000 patients in iQemo, including those who are chemotherapy inpatients and attend the Cancer Day Centre on a daily basis.

In addition to the Royal Adelaide Hospital, iQemo has been successfully implemented at the Queen Elizabeth Hospital, Lyell McEwin Hospital, as well as throughout the regional local health networks. The rollout of these sites is being progressively implemented, with the goal of completing all 21 public hospital sites across metropolitan and regional South Australia by the end of 2025, to support patients requiring chemotherapy.

Altera Digital Health, formerly known as Allscripts, secured the competitive contract to deliver this pioneering electronic chemotherapy prescribing solution for SA Health in 2021. iQemo is a stand-alone, cloud-based system exclusively available through Altera Digital Health in Australia and New Zealand. It aims to improve patient safety by streamlining the prescribing of complex chemotherapy treatments through its intuitive user interface, allowing clinicians to focus more on patient care and less on administrative tasks.

“Clinicians at these major hospitals are now experiencing the advantages of a tested solution that greatly improves workflow efficiency and most importantly patient safety” said Todd Haebich, Executive Vice President, APAC, Altera Digital Health. “These iQemo implementations in Australia mark a significant step forward in enhancing oncology services. Used standalone or by integrating with the existing Sunrise EMR, iQemo delivers an elevated standard of patient care and we are excited to expand this capability to other sites across South Australia.”

The iQemo solution includes predefined protocols, prescribing, scheduling, dispensing, chemotherapy administration and comprehensive reporting. As a web-based system, iQemo minimises the risk of human error in clinical settings, ensuring safer and more efficient treatment processes.

About Altera Digital Health

A global healthcare IT leader, Altera Digital Health develops and elevates technology to bring next-level healthcare within reach. Altera’s approach to our solutions is changing the way healthcare is delivered—we see the summit of what healthcare can be, but rather than total transformation, we’re focused on helping organizations take the steps they need to get there. Altera designs digital health services that lead healthcare to a higher place, while we guide those we partner with, all along the way. To learn more, visit au.alterahealth.com.

For more information contact: alteramediarelations@alterahealth.com.